Cargando…

The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species

PURPOSE: The melatonin receptor (MT) agonist ramelteon has a higher affinity to MT1 than for MT2 receptors and induces cardioprotection by involvement of mitochondrial potassium channels. Activation of mitochondrial potassium channels leads to release of free radicals. We investigated whether (1) ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stroethoff, Martin, Goetze, Lukas, Torregroza, Carolin, Bunte, Sebastian, Raupach, Annika, Heinen, André, Mathes, Alexander, Hollmann, Markus W., Huhn, Ragnar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242242/ https://www.ncbi.nlm.nih.gov/pubmed/32236860 http://dx.doi.org/10.1007/s10557-020-06972-4

Ejemplares similares

Activation of PKG and Akt Is Required for Cardioprotection by Ramelteon-Induced Preconditioning and Is Located Upstream of mKCa-Channels
por: Torregroza, Carolin, et al.
Publicado: (2020)

Influence of Hyperglycemia on Dexmedetomidine-Induced Cardioprotection in the Isolated Perfused Rat Heart
por: Torregroza, Carolin, et al.
Publicado: (2020)

Effluent from ischemic preconditioned hearts confers cardioprotection independent of the number of preconditioning cycles
por: Feige, Katharina, et al.
Publicado: (2020)

Cardioprotective Properties of Mannitol—Involvement of Mitochondrial Potassium Channels
por: Feige, Katharina, et al.
Publicado: (2021)

Milrinone-Induced Pharmacological Preconditioning in Cardioprotection: Hints for a Role of Mitochondrial Mechanisms
por: Raupach, Annika, et al.
Publicado: (2019)

Impact of Anesthetics on Cardioprotection Induced by Pharmacological Preconditioning
por: Bunte, Sebastian, et al.
Publicado: (2019)

Influence of Hyperglycemia and Diabetes on Cardioprotection by Humoral Factors Released after Remote Ischemic Preconditioning (RIPC)
por: Torregroza, Carolin, et al.
Publicado: (2021)

Mediation of the Cardioprotective Effects of Mannitol Discovered, with Refutation of Common Protein Kinases
por: Torregroza, Carolin, et al.
Publicado: (2021)

Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia
por: Torregroza, Carolin, et al.
Publicado: (2021)

Cardioprotective Properties of Omecamtiv Mecarbil against Ischemia and Reperfusion Injury
por: Stroethoff, Martin, et al.
Publicado: (2019)

Influence of Short and Long Hyperglycemia on Cardioprotection by Remote Ischemic Preconditioning—A Translational Approach
por: Feige, Katharina, et al.
Publicado: (2022)

Cardioprotective Properties of Humoral Factors Released after Remote Ischemic Preconditioning in CABG Patients with Propofol-Free Anesthesia—A Translational Approach from Bedside to Bench
por: Feige, Katharina, et al.
Publicado: (2022)

Endogenous and Exogenous Melatonin Exposure Attenuates Hepatic MT(1) Melatonin Receptor Protein Expression in Rat
por: Mathes, Alexander M., et al.
Publicado: (2019)

The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
por: Kawabe, Kentaro, et al.
Publicado: (2014)

Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury
por: Wu, Xiao-li, et al.
Publicado: (2020)

Pharmacology of Ramelteon, a Selective MT(1)/MT(2) Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders
por: Miyamoto, Masaomi
Publicado: (2009)

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010)

Pharmacological Cardioprotection against Ischemia Reperfusion Injury—The Search for a Clinical Effective Therapy
por: Wang, Qian, et al.
Publicado: (2023)

Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials
por: Kishi, Taro, et al.
Publicado: (2019)

New MT(2) Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists
por: Boutin, Jean A., et al.
Publicado: (2017)

MiR-21-5p but not miR-1-3p expression is modulated by preconditioning in a rat model of myocardial infarction
por: Raupach, Annika, et al.
Publicado: (2020)

Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial*
por: Nishikimi, Mitsuaki, et al.
Publicado: (2018)

Impact of Mitochondrial Ca(2+)-Sensitive Potassium (mBK(Ca)) Channels in Sildenafil-Induced Cardioprotection in Rats
por: Behmenburg, Friederike, et al.
Publicado: (2015)

Haemotherapy with Fibrinogen for Perioperative Bleeding Prevention—A View on Arterial Thrombogenesis and Myocardial Infarction in the Rat In Vivo
por: Heinen, André, et al.
Publicado: (2019)

Perioperative Kardioprotektion – „From bench to bedside“: Aktuelle experimentelle Evidenz und mögliche Gründe für die limitierte Translation in die klinische Praxis
por: Torregroza, Carolin, et al.
Publicado: (2021)

Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT(1) and MT(2) receptors
por: Legros, Céline, et al.
Publicado: (2019)

Structural Basis for Agonistic Activity and Selectivity toward Melatonin Receptors hMT1 and hMT2
por: Cantarini, Mattia, et al.
Publicado: (2023)

Bilirubin—A Possible Prognostic Mortality Marker for Patients with ECLS
por: Bunte, Sebastian, et al.
Publicado: (2020)

PT628. First in class melatonin MT2 receptors agonists for neuropathic pain
por: Gobbi, Gabriella, et al.
Publicado: (2016)

Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications
por: Roth, Sebastian, et al.
Publicado: (2021)

Melatonin MT(1) and MT(2) Receptors in the Ram Reproductive Tract
por: González-Arto, Marta, et al.
Publicado: (2017)

The release of cardioprotective humoral factors after remote ischemic preconditioning in humans is age- and sex-dependent
por: Heinen, André, et al.
Publicado: (2018)

Sleep-promoting action of IIK7, a selective MT(2) melatonin receptor agonist in the rat
por: Fisher, Simon P., et al.
Publicado: (2009)

Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2
por: Yadalam, Pradeep Kumar, et al.
Publicado: (2022)

Human Gastroenteropancreatic Expression of Melatonin and Its Receptors MT1 and MT2
por: Söderquist, Fanny, et al.
Publicado: (2015)

The Melatonin Agonist Ramelteon Induces Duration-Dependent Clock Gene Expression through cAMP Signaling in Pancreatic INS-1 β-Cells
por: Nishiyama, Keiji, et al.
Publicado: (2014)

Ramelteon, as a Melatonin Agonist, is Expected to be Effective on COVID-19 Induced Organ Damage: The Hypothetic Role of NF-κB Signaling Pathway
por: Mehdipoor, Mahdis, et al.
Publicado: (2022)

Pistacia vera Extract Potentiates the Effect of Melatonin on Human Melatonin MT(1) and MT(2) Receptors with Functional Selectivity
por: Labani, Nedjma, et al.
Publicado: (2023)

Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
por: Marupuru, Srujitha, et al.
Publicado: (2022)

New Radioligands for Describing the Molecular Pharmacology of MT(1) and MT(2) Melatonin Receptors
por: Legros, Céline, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ig573dtb60e94pg40v62nc9n87